基本信息
浏览量:356
职业迁徙
个人简介
Daniel Catenacci, MD, is an adult gastrointestinal medical oncologist and director of the Gastrointestinal Oncology Program at the University of Chicago. He serves as the assistant director of translational research in the Comprehensive Cancer Center.
In addition to his clinical practice, Dr. Catenacci is an active basic and clinical researcher, focusing on the treatment of gastroesophageal (esophagus, gastroesophageal junction, and stomach) cancers. His bench-to-bedside translational research has an overarching goal to validate and improve personalized treatment, immunotherapy, and precision medicine for gastroesophageal cancer and other GI cancers. A major focus of his research is on the quantification of tumor genetic molecular heterogeneity both between individuals with gastroesophageal cancer, but importantly also within a given individual within one tumor site, and from one tumor site to another, and how this impacts personalized targeted therapeutic approaches. Additionally, Dr. Catenacci designs and executes novel clinical trials to implement treatment strategies based on these laboratory and clinical discoveries. Dr. Catenacci serves as associate editor for the Journal of American Medical Association Network Open (JAMA Netw Open) and is on the editorial board of the Journal of Clinical Oncology Precision Oncology (J Clin Oncol PO).
Memberships & Medical Societies
Medical Council of Canada
Alpha Omega Alpha Honor Medical Society
American Association for Cancer Research
American College of Physicians
American Society of Clinical Oncology
In addition to his clinical practice, Dr. Catenacci is an active basic and clinical researcher, focusing on the treatment of gastroesophageal (esophagus, gastroesophageal junction, and stomach) cancers. His bench-to-bedside translational research has an overarching goal to validate and improve personalized treatment, immunotherapy, and precision medicine for gastroesophageal cancer and other GI cancers. A major focus of his research is on the quantification of tumor genetic molecular heterogeneity both between individuals with gastroesophageal cancer, but importantly also within a given individual within one tumor site, and from one tumor site to another, and how this impacts personalized targeted therapeutic approaches. Additionally, Dr. Catenacci designs and executes novel clinical trials to implement treatment strategies based on these laboratory and clinical discoveries. Dr. Catenacci serves as associate editor for the Journal of American Medical Association Network Open (JAMA Netw Open) and is on the editorial board of the Journal of Clinical Oncology Precision Oncology (J Clin Oncol PO).
Memberships & Medical Societies
Medical Council of Canada
Alpha Omega Alpha Honor Medical Society
American Association for Cancer Research
American College of Physicians
American Society of Clinical Oncology
研究兴趣
论文共 303 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
A.V. Serritella, N.K.S. Grewal, B. Peterson, K. Arndt,D.D. Gaudio, P. Liu, A. Shergill, B. Polite, H.L. Kindler,D.V.T. Catenacci,C.Y. Liao
ESMO Gastrointestinal Oncology (2023): 100012
引用0浏览0引用
0
0
Desiree Schenk, Rita Zhou, Olivia Petrillo, Alexis Mantilla, Italo Faria do Valle,Steven Maron,Brian S. Henick,Chih-Yi Liao,Daniel V. T. Catenacci,Sameek Roychowdhury,Benjamin Solomon, Alexander I. Spira,
CANCER RESEARCHno. 7 (2023): 1126-1126
crossref(2023)
crossref(2023)
Daniel Vt Catenacci,Yoon-Koo Kang,Hope E Uronis,Keun-Wook Lee, Matthew Ch Ng,Peter C Enzinger,Se Hoon Park, Philip J Gold,Jill Lacy,Howard S Hochster,Sang Cheul Oh,Yeul Hong Kim,
Divya Sood, Marie L. Fefferman,Natalie Marie Reizine,Ryan B. Morgan, Cecilia T. Ong,Ankit Dhiman,Kiran Turaga,Daniel V. T. Catenacci,Oliver Eng
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn